The National Institute for Occupational Safety and Health (NIOSH), Personal Protective Technology (PPT) Program and National Personal Protective Technology Laboratory (NPPTL) will hold its fourth stakeholder meeting on March 29, 2011, at the Hyatt Regency Pittsburgh Airport.
This meeting will provide an opportunity to communicate directly with NIOSH employees and NIOSH grant recipients about their current research projects and other workplace safety and topics that are affecting the healthcare industry. The meeting will emphasize personal protective equipment (PPE) in healthcare as well as other industries.
In addition to breakout sessions, poster and equipment displays of protective ensembles and respirators will be present and related demonstrations will be given for each industry sector. Gordon Graham will be the luncheon keynote speaker and will address the topic of "Personal Protective Technology and Risk Management."
Those individuals who are interested in learning about current and anticipated PPE research and initiatives are invited to attend' practitioners are also encouraged to assist NIOSH by communicating their unique insights as a stakeholders in the healthcare field.
To stay informed of meeting updates, check the NPPTL website (http://www.cdc.gov/niosh/npptl), subscribe to the listserv (http://www.cdc.gov/niosh/npptl/sub-NPPTL.html), and check updates on the NIOSH Facebook and Twitter (http://www.twitter.com/NIOSH) pages. You may register electronically or you can download the Adobe PDF and fax it to (412) 386-4951. On-site registration also will be available, but space is limited. This meeting will also be available through remote access capabilities (Microsoft Live Meeting), whereby participants can simultaneously listen and participate over the Internet. To register to attend by remote access, complete the registration form and check the "remote access attendee" block. This option will be available to participants on a first-come, first-serve basis and is limited to the first 100 participants. Additional information will be posted to the NPPTL website prior to the meeting as it become available.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.